Company Performance: Strong earnings reports, revenue growth, and positive guidance typically lead to stock price increases. Conversely, weak financial results can negatively impact the price.

Industry Trends: The overall health and outlook of the biotechnology sector influences investor sentiment towards SGRY.US. Positive industry developments can drive up the price.

Regulatory Environment: Changes in government regulations regarding drug approvals, pricing, and healthcare policies can significantly affect the company's profitability and, consequently, its stock price.

Clinical Trial Results: Positive data from clinical trials for the company's drug candidates usually result in price surges, while negative or inconclusive results can cause declines.

Competition: The presence of competitors with similar products or technologies can affect market share and pricing power, impacting the stock price.

Market Sentiment: Overall investor confidence and risk appetite in the stock market can influence demand for SGRY.US shares. Bull markets tend to lift most stocks, while bear markets can drag them down.

News and Events: Major announcements, partnerships, acquisitions, or adverse events related to the company or its products can cause immediate price fluctuations.